Raymond James Financial Inc. Takes Position in United Therapeutics Co. (NASDAQ:UTHR)
Raymond James Financial Inc. purchased a new position in United Therapeutics Co. (NASDAQ:UTHR – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 51,744 shares of the biotechnology company’s stock, valued at approximately $18,257,000. A number of other […]
Raymond James Financial Inc. purchased a new position in United Therapeutics Co. (NASDAQ:UTHR – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 51,744 shares of the biotechnology company’s stock, valued at approximately $18,257,000. A number of other […]
